Your browser doesn't support javascript.
loading
Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT.
Kröger, Nicolaus; Sbianchi, Giulia; Sirait, Tiarlan; Wolschke, Christine; Beelen, Dietrich; Passweg, Jakob; Robin, Marie; Vrhovac, Radovan; Helbig, Grzegorz; Sockel, Katja; Conneally, Eibhlin; Rubio, Marie Thérèse; Beguin, Yves; Finke, Jürgen; Bernasconi, Paolo; Morozova, Elena; Clausen, Johannes; von dem Borne, Peter; Schaap, Nicolaas; Schroyens, Wilfried; Patriarca, Francesca; Di Renzo, Nicola; Yegin, Zeynep Arzu; Hayden, Patrick; McLornan, Donal; Yakoub-Agha, Ibrahim.
Afiliação
  • Kröger N; Department of Stem Cell Transplantation University Medical Center Hamburg-Eppendorf, Hamburg, Germany. nkroeger@uke.uni-hamburg.de.
  • Sbianchi G; Department of Biology, University of Rome "Tor Vergata", Rome, Italy.
  • Sirait T; EBMT Data Office, Leiden, Netherlands.
  • Wolschke C; Department of Stem Cell Transplantation University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Beelen D; Essen University Hospital, Essen, Germany.
  • Passweg J; University Hospital of Basel, Basel, Switzerland.
  • Robin M; Hopital St. Louis, Paris, France.
  • Vrhovac R; University Hospital Center Rebro, Zagreb, Croatia.
  • Helbig G; Silesian Medica Academy, Katowice, Poland.
  • Sockel K; University Hospital Dresden, Dresden, Germany.
  • Conneally E; Hope Directorate St. James's Hospital, Dublin, Ireland.
  • Rubio MT; Hopital d'Enfants, Vandoeuvre Nancy, France.
  • Beguin Y; University of Liege and CHU of Liege, Liege, Belgium.
  • Finke J; University of Freiburg, Freiburg, Germany.
  • Bernasconi P; IRCCS Policlinico San Matteo, Pavia, Italy.
  • Morozova E; First State Pavlov Medical University of St. Petersburg, St. Petersburg, Russia.
  • Clausen J; Ordensklinikum Linz - Elisabethinen, Linz, Austria.
  • von dem Borne P; Leiden University Hospital, Leiden, Netherlands.
  • Schaap N; Radboud University Medical Centre, Nijmegen, Netherlands.
  • Schroyens W; Antwerp University Hospital (UZA), Antwerp Edegem, Belgium.
  • Patriarca F; Division of Hematology and Stem Cell Transplantation Center, University Hospital and DAME, Udine, Italy.
  • Di Renzo N; Unita Operativa di Ematologia e Trapianto di Cellule Staminali, Lecce, Italy.
  • Yegin ZA; Gazi University Faculty of Medicine, Ankara, Turkey.
  • Hayden P; Department of Haematology, Trinity College Dublin, St. James's Hospital, Dublin 8, Ireland.
  • McLornan D; Department of Haematology, Guy's Hospital and Department of Stem Cell Transplantation, University College London Hospital, London, England.
  • Yakoub-Agha I; CHU de Lille, Univ Lille, INSERM U1286, Infinite, Lille, France.
Leukemia ; 35(12): 3551-3560, 2021 12.
Article em En | MEDLINE | ID: mdl-34023851
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Transplante de Células-Tronco Hematopoéticas / Mielofibrose Primária / Inibidores de Janus Quinases / Doença Enxerto-Hospedeiro / Nitrilas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Transplante de Células-Tronco Hematopoéticas / Mielofibrose Primária / Inibidores de Janus Quinases / Doença Enxerto-Hospedeiro / Nitrilas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article